Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Developing Countries | 89 | 2024 | 2901 | 6.460 |
Why?
|
Delivery of Health Care | 79 | 2024 | 5367 | 5.450 |
Why?
|
Investments | 15 | 2023 | 149 | 4.430 |
Why?
|
Financing, Organized | 19 | 2023 | 206 | 4.230 |
Why?
|
Tuberculosis | 47 | 2021 | 2029 | 4.180 |
Why?
|
National Health Programs | 16 | 2019 | 442 | 3.850 |
Why?
|
Research Support as Topic | 13 | 2020 | 699 | 3.800 |
Why?
|
Health Policy | 40 | 2021 | 2699 | 3.520 |
Why?
|
Public Sector | 11 | 2020 | 265 | 2.660 |
Why?
|
Biomedical Research | 23 | 2023 | 3463 | 2.630 |
Why?
|
Health Services Accessibility | 49 | 2024 | 5508 | 2.600 |
Why?
|
International Cooperation | 27 | 2020 | 1439 | 2.590 |
Why?
|
Financing, Government | 17 | 2021 | 473 | 2.570 |
Why?
|
Financial Support | 12 | 2016 | 116 | 2.320 |
Why?
|
HIV Infections | 60 | 2022 | 17492 | 2.280 |
Why?
|
Malaria | 20 | 2017 | 1240 | 2.230 |
Why?
|
Health Services Needs and Demand | 21 | 2019 | 1408 | 2.230 |
Why?
|
Research | 13 | 2018 | 1984 | 2.230 |
Why?
|
Health Expenditures | 23 | 2024 | 2391 | 2.210 |
Why?
|
Health Care Reform | 16 | 2019 | 1256 | 2.200 |
Why?
|
Government Programs | 17 | 2023 | 278 | 2.070 |
Why?
|
Health Priorities | 9 | 2021 | 379 | 2.050 |
Why?
|
Capital Financing | 6 | 2014 | 58 | 2.030 |
Why?
|
Poverty | 26 | 2024 | 2719 | 1.980 |
Why?
|
Communicable Disease Control | 18 | 2022 | 857 | 1.970 |
Why?
|
Health Services | 14 | 2023 | 756 | 1.930 |
Why?
|
Private Sector | 12 | 2021 | 395 | 1.890 |
Why?
|
State Medicine | 8 | 2019 | 217 | 1.730 |
Why?
|
Health Care Costs | 18 | 2024 | 3266 | 1.720 |
Why?
|
Policy Making | 7 | 2021 | 545 | 1.690 |
Why?
|
Income | 22 | 2022 | 1878 | 1.620 |
Why?
|
Neoplasms | 31 | 2024 | 22389 | 1.580 |
Why?
|
Financial Management | 3 | 2023 | 161 | 1.500 |
Why?
|
Communicable Diseases | 10 | 2022 | 875 | 1.500 |
Why?
|
Public Health | 20 | 2022 | 2693 | 1.460 |
Why?
|
Primary Health Care | 16 | 2023 | 4736 | 1.460 |
Why?
|
Maternal Mortality | 9 | 2023 | 305 | 1.430 |
Why?
|
Goals | 13 | 2022 | 715 | 1.390 |
Why?
|
Internationality | 6 | 2021 | 1007 | 1.370 |
Why?
|
Delivery of Health Care, Integrated | 8 | 2016 | 952 | 1.350 |
Why?
|
Humans | 387 | 2024 | 768369 | 1.340 |
Why?
|
World Health Organization | 18 | 2021 | 1327 | 1.270 |
Why?
|
Cost of Illness | 13 | 2021 | 1960 | 1.220 |
Why?
|
Diabetes Mellitus | 19 | 2024 | 5887 | 1.210 |
Why?
|
Russia | 28 | 2019 | 386 | 1.200 |
Why?
|
Resource Allocation | 5 | 2017 | 353 | 1.200 |
Why?
|
Leadership | 7 | 2021 | 1395 | 1.190 |
Why?
|
Disabled Persons | 5 | 2023 | 1218 | 1.130 |
Why?
|
Capacity Building | 3 | 2018 | 265 | 1.090 |
Why?
|
Cost-Benefit Analysis | 14 | 2021 | 5532 | 1.090 |
Why?
|
Patient Acceptance of Health Care | 11 | 2020 | 3237 | 1.070 |
Why?
|
Chronic Disease | 12 | 2024 | 9379 | 1.070 |
Why?
|
Fund Raising | 3 | 2023 | 49 | 1.010 |
Why?
|
Computer Simulation | 11 | 2024 | 6278 | 0.990 |
Why?
|
Developed Countries | 7 | 2023 | 451 | 0.990 |
Why?
|
Preventive Health Services | 3 | 2019 | 568 | 0.990 |
Why?
|
Socioeconomic Factors | 29 | 2022 | 7863 | 0.970 |
Why?
|
Caliciviridae Infections | 2 | 2016 | 29 | 0.970 |
Why?
|
Financing, Personal | 2 | 2018 | 310 | 0.960 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 2013 | 2201 | 0.960 |
Why?
|
Norovirus | 2 | 2016 | 37 | 0.950 |
Why?
|
Unemployment | 7 | 2016 | 210 | 0.950 |
Why?
|
Politics | 10 | 2020 | 821 | 0.940 |
Why?
|
Hypertension | 14 | 2024 | 8610 | 0.920 |
Why?
|
Tuberculosis, Pulmonary | 10 | 2012 | 846 | 0.870 |
Why?
|
Child Mortality | 4 | 2015 | 204 | 0.850 |
Why?
|
Antitubercular Agents | 13 | 2012 | 1390 | 0.830 |
Why?
|
Infectious Disease Transmission, Vertical | 5 | 2013 | 1359 | 0.830 |
Why?
|
Self-Injurious Behavior | 2 | 2019 | 571 | 0.830 |
Why?
|
Artificial Intelligence | 5 | 2021 | 2659 | 0.820 |
Why?
|
Hospital Administrators | 2 | 2018 | 57 | 0.820 |
Why?
|
Reminder Systems | 4 | 2013 | 386 | 0.800 |
Why?
|
Health Personnel | 12 | 2022 | 3384 | 0.800 |
Why?
|
Privatization | 2 | 2020 | 41 | 0.790 |
Why?
|
Africa South of the Sahara | 11 | 2017 | 750 | 0.790 |
Why?
|
Health Education | 6 | 2022 | 1059 | 0.780 |
Why?
|
Disease Outbreaks | 8 | 2020 | 1763 | 0.770 |
Why?
|
Insurance, Health | 11 | 2024 | 2513 | 0.770 |
Why?
|
Conservation of Natural Resources | 4 | 2017 | 210 | 0.750 |
Why?
|
Models, Economic | 3 | 2020 | 717 | 0.750 |
Why?
|
Mental Disorders | 8 | 2024 | 6879 | 0.740 |
Why?
|
Transients and Migrants | 2 | 2021 | 170 | 0.730 |
Why?
|
India | 13 | 2024 | 2323 | 0.720 |
Why?
|
Harm Reduction | 4 | 2012 | 144 | 0.720 |
Why?
|
Program Evaluation | 9 | 2019 | 2508 | 0.720 |
Why?
|
Economic Recession | 3 | 2016 | 79 | 0.710 |
Why?
|
Malaysia | 7 | 2023 | 107 | 0.710 |
Why?
|
Diffusion of Innovation | 5 | 2015 | 730 | 0.670 |
Why?
|
Health Planning | 5 | 2015 | 233 | 0.660 |
Why?
|
Survival Analysis | 5 | 2020 | 10127 | 0.660 |
Why?
|
Drug Resistance, Bacterial | 10 | 2023 | 1061 | 0.660 |
Why?
|
Substance Abuse, Intravenous | 5 | 2012 | 530 | 0.650 |
Why?
|
Child Health Services | 2 | 2017 | 645 | 0.640 |
Why?
|
Maternal Welfare | 2 | 2011 | 113 | 0.640 |
Why?
|
Healthcare Disparities | 16 | 2024 | 3412 | 0.640 |
Why?
|
European Union | 7 | 2017 | 157 | 0.630 |
Why?
|
Time | 1 | 2020 | 546 | 0.630 |
Why?
|
Anti-HIV Agents | 10 | 2012 | 4563 | 0.630 |
Why?
|
Prevalence | 31 | 2024 | 15879 | 0.630 |
Why?
|
Prenatal Care | 3 | 2016 | 1159 | 0.620 |
Why?
|
Nervous System Diseases | 2 | 2019 | 1668 | 0.620 |
Why?
|
Anthelmintics | 1 | 2019 | 83 | 0.610 |
Why?
|
Cross-Sectional Studies | 47 | 2024 | 26348 | 0.610 |
Why?
|
Helminthiasis | 1 | 2019 | 81 | 0.600 |
Why?
|
Cities | 2 | 2017 | 545 | 0.590 |
Why?
|
Anti-Infective Agents | 4 | 2023 | 986 | 0.590 |
Why?
|
Female | 124 | 2024 | 396926 | 0.590 |
Why?
|
Tuberculosis, Multidrug-Resistant | 7 | 2012 | 938 | 0.580 |
Why?
|
Information Dissemination | 2 | 2016 | 1138 | 0.580 |
Why?
|
Epidemics | 4 | 2021 | 517 | 0.580 |
Why?
|
Mathematics | 1 | 2019 | 704 | 0.580 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2022 | 3439 | 0.570 |
Why?
|
Directly Observed Therapy | 8 | 2012 | 139 | 0.570 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.560 |
Why?
|
Quality of Health Care | 6 | 2021 | 4340 | 0.560 |
Why?
|
Marburgvirus | 1 | 2016 | 19 | 0.560 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2020 | 2040 | 0.550 |
Why?
|
Program Development | 3 | 2012 | 1296 | 0.550 |
Why?
|
Hepatitis | 2 | 2019 | 228 | 0.540 |
Why?
|
Turkey | 5 | 2019 | 256 | 0.540 |
Why?
|
Mortality | 9 | 2023 | 2917 | 0.530 |
Why?
|
Fees and Charges | 1 | 2017 | 192 | 0.520 |
Why?
|
Charities | 2 | 2013 | 35 | 0.520 |
Why?
|
Work | 1 | 2017 | 195 | 0.520 |
Why?
|
Prisons | 4 | 2012 | 178 | 0.520 |
Why?
|
Hospitals | 7 | 2022 | 3906 | 0.510 |
Why?
|
Hot Temperature | 1 | 2022 | 1438 | 0.510 |
Why?
|
Social Values | 1 | 2016 | 225 | 0.510 |
Why?
|
Hospitals, Public | 3 | 2024 | 205 | 0.510 |
Why?
|
Islets of Langerhans | 1 | 2022 | 1349 | 0.500 |
Why?
|
Government | 4 | 2023 | 162 | 0.500 |
Why?
|
Models, Theoretical | 8 | 2021 | 3590 | 0.500 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 590 | 0.490 |
Why?
|
Decision Making, Organizational | 2 | 2013 | 136 | 0.490 |
Why?
|
Population Surveillance | 4 | 2019 | 2601 | 0.490 |
Why?
|
Computer-Assisted Instruction | 1 | 2018 | 364 | 0.490 |
Why?
|
Antimalarials | 3 | 2012 | 910 | 0.490 |
Why?
|
Primary Prevention | 5 | 2024 | 1189 | 0.490 |
Why?
|
Academies and Institutes | 2 | 2014 | 326 | 0.490 |
Why?
|
China | 10 | 2023 | 2397 | 0.490 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2010 | 664 | 0.480 |
Why?
|
Cardiovascular Diseases | 14 | 2024 | 15638 | 0.480 |
Why?
|
Adult | 80 | 2024 | 223528 | 0.480 |
Why?
|
United Nations | 6 | 2018 | 150 | 0.480 |
Why?
|
Urban Health | 1 | 2017 | 535 | 0.480 |
Why?
|
Anti-Retroviral Agents | 4 | 2022 | 1792 | 0.480 |
Why?
|
Male | 96 | 2024 | 364761 | 0.470 |
Why?
|
Risk Reduction Behavior | 3 | 2011 | 1120 | 0.470 |
Why?
|
Health Surveys | 9 | 2024 | 4056 | 0.470 |
Why?
|
Hospitalization | 5 | 2022 | 10845 | 0.470 |
Why?
|
Diabetes Complications | 2 | 2021 | 1322 | 0.470 |
Why?
|
Health Resources | 5 | 2019 | 950 | 0.460 |
Why?
|
Urban Population | 5 | 2022 | 2047 | 0.460 |
Why?
|
Rural Population | 6 | 2022 | 2317 | 0.460 |
Why?
|
Ebolavirus | 1 | 2016 | 250 | 0.450 |
Why?
|
Gastroenteritis | 1 | 2016 | 236 | 0.450 |
Why?
|
Drug Resistance, Microbial | 2 | 2014 | 829 | 0.450 |
Why?
|
Appointments and Schedules | 3 | 2013 | 443 | 0.450 |
Why?
|
Child | 32 | 2022 | 80856 | 0.440 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2016 | 2181 | 0.440 |
Why?
|
Colonialism | 1 | 2014 | 35 | 0.440 |
Why?
|
Asia | 7 | 2013 | 627 | 0.440 |
Why?
|
Disease | 2 | 2016 | 672 | 0.440 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2014 | 134 | 0.430 |
Why?
|
Health Services Research | 9 | 2020 | 1815 | 0.430 |
Why?
|
Safety | 2 | 2017 | 1159 | 0.430 |
Why?
|
Healthy People Programs | 2 | 2012 | 54 | 0.430 |
Why?
|
Perinatal Care | 2 | 2013 | 245 | 0.430 |
Why?
|
Health Plan Implementation | 3 | 2013 | 338 | 0.430 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2021 | 1898 | 0.430 |
Why?
|
Cost Savings | 3 | 2020 | 917 | 0.430 |
Why?
|
International Agencies | 2 | 2013 | 245 | 0.430 |
Why?
|
Regression Analysis | 12 | 2021 | 6353 | 0.420 |
Why?
|
Surgical Procedures, Operative | 3 | 2024 | 1937 | 0.420 |
Why?
|
Ghana | 4 | 2019 | 319 | 0.420 |
Why?
|
Publications | 1 | 2015 | 196 | 0.420 |
Why?
|
Models, Statistical | 5 | 2021 | 5103 | 0.420 |
Why?
|
Estonia | 4 | 2016 | 56 | 0.410 |
Why?
|
Health Promotion | 5 | 2014 | 2215 | 0.410 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 699 | 0.400 |
Why?
|
Bibliometrics | 1 | 2016 | 354 | 0.400 |
Why?
|
Health Care Surveys | 8 | 2020 | 2437 | 0.400 |
Why?
|
Workload | 2 | 2019 | 852 | 0.400 |
Why?
|
Substance-Related Disorders | 3 | 2022 | 4453 | 0.390 |
Why?
|
Infection Control | 3 | 2019 | 985 | 0.390 |
Why?
|
Personal Satisfaction | 1 | 2016 | 648 | 0.390 |
Why?
|
Infant | 21 | 2021 | 36496 | 0.390 |
Why?
|
Adolescent | 36 | 2024 | 89163 | 0.380 |
Why?
|
Early Detection of Cancer | 5 | 2020 | 3230 | 0.380 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 424 | 0.380 |
Why?
|
Interprofessional Relations | 3 | 2008 | 997 | 0.380 |
Why?
|
Systems Integration | 2 | 2010 | 429 | 0.370 |
Why?
|
Insurance Coverage | 4 | 2024 | 1946 | 0.370 |
Why?
|
Career Choice | 1 | 2017 | 769 | 0.370 |
Why?
|
Middle Aged | 59 | 2024 | 223406 | 0.370 |
Why?
|
Community Health Planning | 1 | 2011 | 164 | 0.360 |
Why?
|
Mexico | 5 | 2019 | 766 | 0.350 |
Why?
|
History, 21st Century | 5 | 2017 | 1575 | 0.350 |
Why?
|
Europe | 7 | 2022 | 3439 | 0.350 |
Why?
|
Antihypertensive Agents | 4 | 2021 | 2028 | 0.350 |
Why?
|
Vaccines | 2 | 2022 | 845 | 0.350 |
Why?
|
Brazil | 7 | 2021 | 1247 | 0.350 |
Why?
|
Budgets | 6 | 2016 | 232 | 0.350 |
Why?
|
Systems Analysis | 4 | 2018 | 169 | 0.350 |
Why?
|
Ambulatory Care | 3 | 2020 | 2780 | 0.340 |
Why?
|
HIV Seropositivity | 4 | 2011 | 963 | 0.340 |
Why?
|
Delayed Diagnosis | 3 | 2021 | 469 | 0.340 |
Why?
|
Infant, Newborn | 14 | 2020 | 26394 | 0.340 |
Why?
|
Child, Preschool | 19 | 2021 | 42620 | 0.340 |
Why?
|
Health Status | 4 | 2018 | 4096 | 0.330 |
Why?
|
Concept Formation | 1 | 2010 | 162 | 0.330 |
Why?
|
Cardiology | 1 | 2020 | 1701 | 0.330 |
Why?
|
Pregnancy | 20 | 2023 | 30179 | 0.320 |
Why?
|
Perception | 1 | 2015 | 1207 | 0.320 |
Why?
|
Models, Organizational | 5 | 2021 | 546 | 0.320 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 151 | 0.320 |
Why?
|
Perinatology | 1 | 2009 | 63 | 0.310 |
Why?
|
Latin America | 5 | 2022 | 416 | 0.310 |
Why?
|
Neglected Diseases | 3 | 2014 | 67 | 0.310 |
Why?
|
Medically Underserved Area | 1 | 2011 | 266 | 0.310 |
Why?
|
Telephone | 1 | 2012 | 630 | 0.310 |
Why?
|
Family Practice | 4 | 2019 | 510 | 0.310 |
Why?
|
Pandemics | 8 | 2023 | 8751 | 0.310 |
Why?
|
Review Literature as Topic | 3 | 2021 | 354 | 0.300 |
Why?
|
Publishing | 1 | 2015 | 836 | 0.300 |
Why?
|
Medical Informatics | 1 | 2015 | 737 | 0.300 |
Why?
|
Interdisciplinary Communication | 4 | 2016 | 937 | 0.300 |
Why?
|
Internet | 2 | 2017 | 3123 | 0.290 |
Why?
|
Bacterial Infections | 3 | 2023 | 1397 | 0.290 |
Why?
|
Life Expectancy | 4 | 2021 | 1249 | 0.290 |
Why?
|
Survival Rate | 6 | 2024 | 12875 | 0.290 |
Why?
|
Economic Development | 3 | 2020 | 72 | 0.290 |
Why?
|
Aged | 41 | 2024 | 171514 | 0.290 |
Why?
|
Reproductive Medicine | 1 | 2009 | 99 | 0.290 |
Why?
|
Social Adjustment | 1 | 2010 | 635 | 0.290 |
Why?
|
Self Care | 1 | 2012 | 798 | 0.280 |
Why?
|
Blood Banks | 1 | 2008 | 108 | 0.280 |
Why?
|
Incidence | 11 | 2024 | 21552 | 0.280 |
Why?
|
Young Adult | 28 | 2024 | 60038 | 0.280 |
Why?
|
Mental Health Services | 2 | 2010 | 1732 | 0.280 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1813 | 0.280 |
Why?
|
Infant Mortality | 4 | 2016 | 756 | 0.280 |
Why?
|
Hospital Design and Construction | 1 | 2006 | 33 | 0.270 |
Why?
|
Contract Services | 1 | 2006 | 90 | 0.270 |
Why?
|
Financing, Construction | 1 | 2005 | 1 | 0.260 |
Why?
|
Family | 1 | 2017 | 3208 | 0.260 |
Why?
|
Respiratory Tract Infections | 1 | 2014 | 1013 | 0.260 |
Why?
|
Hospitals, Convalescent | 1 | 2005 | 3 | 0.260 |
Why?
|
Hepatitis B | 3 | 2020 | 707 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2019 | 10358 | 0.260 |
Why?
|
Cross Infection | 2 | 2016 | 1425 | 0.260 |
Why?
|
Disease Management | 1 | 2016 | 2533 | 0.260 |
Why?
|
Cause of Death | 5 | 2015 | 3727 | 0.260 |
Why?
|
Dietary Services | 1 | 2005 | 17 | 0.260 |
Why?
|
Drugs, Investigational | 1 | 2008 | 213 | 0.260 |
Why?
|
Marketing | 1 | 2008 | 224 | 0.250 |
Why?
|
Drug Discovery | 1 | 2013 | 1062 | 0.250 |
Why?
|
Hypercholesterolemia | 2 | 2023 | 1142 | 0.250 |
Why?
|
Risk Factors | 27 | 2024 | 74915 | 0.250 |
Why?
|
History, 20th Century | 5 | 2018 | 2772 | 0.250 |
Why?
|
CD4 Lymphocyte Count | 4 | 2016 | 2589 | 0.250 |
Why?
|
Blood Pressure | 5 | 2021 | 8537 | 0.250 |
Why?
|
Drug Resistance, Multiple | 1 | 2006 | 255 | 0.250 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12242 | 0.240 |
Why?
|
Drug Industry | 2 | 2010 | 793 | 0.240 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 1274 | 0.240 |
Why?
|
Health Status Indicators | 1 | 2010 | 971 | 0.240 |
Why?
|
Family Health | 3 | 2018 | 1256 | 0.240 |
Why?
|
Antiviral Agents | 2 | 2020 | 3062 | 0.240 |
Why?
|
Artemisinins | 3 | 2012 | 218 | 0.240 |
Why?
|
Evidence-Based Medicine | 7 | 2019 | 3708 | 0.230 |
Why?
|
Botswana | 2 | 2019 | 1059 | 0.230 |
Why?
|
Social Welfare | 1 | 2005 | 87 | 0.230 |
Why?
|
Acute Disease | 1 | 2015 | 7245 | 0.230 |
Why?
|
Organizational Innovation | 4 | 2013 | 540 | 0.230 |
Why?
|
Students, Medical | 1 | 2017 | 1962 | 0.230 |
Why?
|
Wounds and Injuries | 2 | 2024 | 2518 | 0.220 |
Why?
|
Down Syndrome | 1 | 2012 | 914 | 0.220 |
Why?
|
Nutritional Support | 1 | 2005 | 178 | 0.220 |
Why?
|
Policy | 4 | 2023 | 515 | 0.220 |
Why?
|
Forecasting | 4 | 2023 | 2950 | 0.220 |
Why?
|
Pneumonia | 1 | 2015 | 2162 | 0.220 |
Why?
|
Quality of Life | 4 | 2022 | 13497 | 0.220 |
Why?
|
Hospital-Physician Relations | 1 | 2003 | 17 | 0.220 |
Why?
|
Organizational Case Studies | 4 | 2019 | 301 | 0.220 |
Why?
|
Organizational Objectives | 2 | 2019 | 427 | 0.210 |
Why?
|
Disease Transmission, Infectious | 2 | 2018 | 562 | 0.210 |
Why?
|
Patient Rights | 3 | 2013 | 127 | 0.210 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2023 | 219 | 0.210 |
Why?
|
Malaria, Falciparum | 2 | 2010 | 1079 | 0.210 |
Why?
|
Hospital Administration | 1 | 2006 | 353 | 0.210 |
Why?
|
Diagnostic Imaging | 3 | 2021 | 3543 | 0.210 |
Why?
|
Needs Assessment | 4 | 2010 | 1146 | 0.210 |
Why?
|
England | 5 | 2022 | 533 | 0.210 |
Why?
|
Time Factors | 12 | 2020 | 40271 | 0.210 |
Why?
|
Comorbidity | 6 | 2019 | 10601 | 0.200 |
Why?
|
Geography | 3 | 2021 | 654 | 0.200 |
Why?
|
Drug Costs | 1 | 2010 | 1196 | 0.200 |
Why?
|
Cold Temperature | 2 | 2022 | 786 | 0.200 |
Why?
|
Safety Management | 2 | 2019 | 764 | 0.200 |
Why?
|
Mothers | 1 | 2013 | 2210 | 0.200 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1734 | 0.200 |
Why?
|
Interinstitutional Relations | 3 | 2009 | 236 | 0.200 |
Why?
|
Aspirin | 2 | 2024 | 3139 | 0.200 |
Why?
|
Referral and Consultation | 2 | 2012 | 3629 | 0.190 |
Why?
|
Medically Uninsured | 2 | 2018 | 841 | 0.190 |
Why?
|
Obstetrics | 1 | 2009 | 676 | 0.190 |
Why?
|
Herpes Genitalis | 1 | 2022 | 149 | 0.190 |
Why?
|
Hospital Costs | 2 | 2019 | 959 | 0.190 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2005 | 389 | 0.190 |
Why?
|
Longevity | 1 | 2009 | 1078 | 0.190 |
Why?
|
Tobacco, Smokeless | 1 | 2022 | 134 | 0.190 |
Why?
|
Attitude of Health Personnel | 4 | 2017 | 3922 | 0.190 |
Why?
|
Sexual Behavior | 1 | 2011 | 2200 | 0.190 |
Why?
|
Hepatitis C | 3 | 2020 | 1594 | 0.190 |
Why?
|
Fetal Blood | 1 | 2008 | 1353 | 0.190 |
Why?
|
Health Systems Plans | 2 | 2019 | 20 | 0.180 |
Why?
|
Research Design | 7 | 2021 | 6217 | 0.180 |
Why?
|
Health Planning Support | 1 | 2000 | 9 | 0.180 |
Why?
|
Health Facilities | 2 | 2023 | 576 | 0.180 |
Why?
|
Glutamate Decarboxylase | 1 | 2022 | 239 | 0.180 |
Why?
|
Social Class | 5 | 2022 | 2000 | 0.180 |
Why?
|
Europe, Eastern | 2 | 2010 | 72 | 0.180 |
Why?
|
Chile | 1 | 2021 | 258 | 0.180 |
Why?
|
Cooperative Behavior | 4 | 2015 | 1514 | 0.180 |
Why?
|
Qatar | 1 | 2020 | 40 | 0.180 |
Why?
|
Health Behavior | 2 | 2012 | 2649 | 0.180 |
Why?
|
Medication Errors | 3 | 2017 | 783 | 0.180 |
Why?
|
Endemic Diseases | 2 | 2012 | 191 | 0.170 |
Why?
|
Sex Factors | 6 | 2021 | 10647 | 0.170 |
Why?
|
Age Distribution | 4 | 2019 | 2881 | 0.170 |
Why?
|
Health Status Disparities | 3 | 2020 | 1876 | 0.170 |
Why?
|
Dancing | 1 | 2021 | 105 | 0.170 |
Why?
|
Anti-Bacterial Agents | 7 | 2023 | 7467 | 0.170 |
Why?
|
El Salvador | 1 | 2019 | 34 | 0.170 |
Why?
|
Catastrophic Illness | 1 | 2020 | 60 | 0.170 |
Why?
|
Hepatitis B virus | 2 | 2020 | 530 | 0.170 |
Why?
|
Medical Assistance | 2 | 2017 | 108 | 0.170 |
Why?
|
Philippines | 1 | 2019 | 95 | 0.170 |
Why?
|
Health Planning Organizations | 1 | 2019 | 13 | 0.170 |
Why?
|
Algorithms | 2 | 2019 | 14157 | 0.170 |
Why?
|
Educational Status | 3 | 2020 | 2519 | 0.160 |
Why?
|
Breast Neoplasms | 5 | 2022 | 21157 | 0.160 |
Why?
|
Palliative Care | 4 | 2019 | 3644 | 0.160 |
Why?
|
Patient Satisfaction | 4 | 2019 | 3484 | 0.160 |
Why?
|
Databases, Factual | 6 | 2015 | 8081 | 0.160 |
Why?
|
Organizational Culture | 2 | 2019 | 510 | 0.160 |
Why?
|
Seasons | 1 | 2005 | 1526 | 0.160 |
Why?
|
Urban Health Services | 1 | 2020 | 177 | 0.160 |
Why?
|
Guatemala | 1 | 2019 | 161 | 0.160 |
Why?
|
Population Groups | 2 | 2021 | 208 | 0.160 |
Why?
|
Economics | 1 | 2019 | 141 | 0.160 |
Why?
|
Coercion | 1 | 2019 | 69 | 0.160 |
Why?
|
Health Services Administration | 2 | 2012 | 63 | 0.160 |
Why?
|
Central America | 1 | 2018 | 69 | 0.160 |
Why?
|
Attitude to Health | 1 | 2008 | 2030 | 0.160 |
Why?
|
Costs and Cost Analysis | 3 | 2020 | 1670 | 0.160 |
Why?
|
Social Participation | 1 | 2021 | 185 | 0.160 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 603 | 0.160 |
Why?
|
Democratic People's Republic of Korea | 1 | 2018 | 12 | 0.160 |
Why?
|
Financial Management, Hospital | 1 | 2019 | 70 | 0.160 |
Why?
|
Environmental Microbiology | 1 | 2018 | 47 | 0.150 |
Why?
|
Republic of Korea | 1 | 2020 | 587 | 0.150 |
Why?
|
South America | 1 | 2018 | 180 | 0.150 |
Why?
|
Education, Distance | 1 | 2022 | 261 | 0.150 |
Why?
|
Breast Feeding | 2 | 2020 | 1365 | 0.150 |
Why?
|
South Africa | 3 | 2019 | 1870 | 0.150 |
Why?
|
Family Characteristics | 2 | 2024 | 1001 | 0.140 |
Why?
|
Africa, Northern | 1 | 2017 | 86 | 0.140 |
Why?
|
Nuclear Medicine | 1 | 2021 | 258 | 0.140 |
Why?
|
Jamaica | 1 | 2017 | 54 | 0.140 |
Why?
|
Information Systems | 3 | 2010 | 397 | 0.140 |
Why?
|
Influenza, Human | 2 | 2021 | 1540 | 0.140 |
Why?
|
Health Occupations | 1 | 2019 | 225 | 0.140 |
Why?
|
Databases as Topic | 1 | 2019 | 475 | 0.140 |
Why?
|
Moldova | 1 | 2016 | 14 | 0.140 |
Why?
|
Marburg Virus Disease | 1 | 2016 | 11 | 0.140 |
Why?
|
Public-Private Sector Partnerships | 3 | 2016 | 123 | 0.140 |
Why?
|
Anxiety | 1 | 2012 | 4655 | 0.140 |
Why?
|
Emigration and Immigration | 1 | 2020 | 405 | 0.140 |
Why?
|
Bacteria | 2 | 2018 | 2226 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1479 | 0.140 |
Why?
|
Radiotherapy | 3 | 2024 | 1510 | 0.140 |
Why?
|
Siberia | 2 | 2007 | 30 | 0.140 |
Why?
|
Middle East | 1 | 2017 | 232 | 0.140 |
Why?
|
Perioperative Care | 1 | 2024 | 1046 | 0.140 |
Why?
|
Africa, Western | 1 | 2016 | 160 | 0.140 |
Why?
|
Indonesia | 3 | 2021 | 129 | 0.140 |
Why?
|
Cote d'Ivoire | 1 | 2016 | 65 | 0.130 |
Why?
|
Drug and Narcotic Control | 1 | 2017 | 146 | 0.130 |
Why?
|
Stereotyping | 2 | 2010 | 243 | 0.130 |
Why?
|
Personnel Turnover | 1 | 2016 | 88 | 0.130 |
Why?
|
Rural Health Services | 1 | 2020 | 392 | 0.130 |
Why?
|
Mental Health | 3 | 2020 | 3271 | 0.130 |
Why?
|
Respiratory Tract Diseases | 2 | 2016 | 749 | 0.130 |
Why?
|
Zimbabwe | 1 | 2016 | 135 | 0.130 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 413 | 0.130 |
Why?
|
Bayes Theorem | 3 | 2021 | 2359 | 0.130 |
Why?
|
Longitudinal Studies | 7 | 2023 | 14766 | 0.130 |
Why?
|
Body Mass Index | 4 | 2021 | 13030 | 0.130 |
Why?
|
Inflation, Economic | 1 | 2016 | 30 | 0.130 |
Why?
|
Employment | 3 | 2011 | 1120 | 0.130 |
Why?
|
Women's Health | 2 | 2016 | 2079 | 0.130 |
Why?
|
Learning | 4 | 2019 | 1762 | 0.130 |
Why?
|
Peripartum Period | 2 | 2020 | 138 | 0.130 |
Why?
|
Gross Domestic Product | 1 | 2016 | 77 | 0.130 |
Why?
|
Job Satisfaction | 1 | 2019 | 549 | 0.130 |
Why?
|
Temperature | 1 | 2022 | 2237 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6979 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1197 | 0.120 |
Why?
|
Escherichia coli Infections | 1 | 2019 | 524 | 0.120 |
Why?
|
General Practice | 1 | 2016 | 100 | 0.120 |
Why?
|
West Indies | 1 | 2014 | 32 | 0.120 |
Why?
|
North America | 1 | 2018 | 1292 | 0.120 |
Why?
|
Age Factors | 4 | 2021 | 18477 | 0.120 |
Why?
|
Medication Reconciliation | 1 | 2016 | 153 | 0.120 |
Why?
|
Interviews as Topic | 4 | 2019 | 2733 | 0.120 |
Why?
|
Immunization Programs | 1 | 2017 | 267 | 0.120 |
Why?
|
Mycology | 1 | 2014 | 13 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2143 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1196 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1568 | 0.110 |
Why?
|
Inappropriate Prescribing | 1 | 2016 | 212 | 0.110 |
Why?
|
Uganda | 1 | 2019 | 1350 | 0.110 |
Why?
|
Clinical Governance | 1 | 2013 | 7 | 0.110 |
Why?
|
Social Isolation | 1 | 2017 | 369 | 0.110 |
Why?
|
Fruit | 1 | 2019 | 1165 | 0.110 |
Why?
|
Vegetables | 1 | 2019 | 1202 | 0.110 |
Why?
|
Motivation | 2 | 2016 | 2034 | 0.110 |
Why?
|
Asthma | 1 | 2012 | 6274 | 0.110 |
Why?
|
Qualitative Research | 4 | 2019 | 3115 | 0.110 |
Why?
|
Prisoners | 3 | 2012 | 317 | 0.110 |
Why?
|
United States | 8 | 2023 | 73120 | 0.110 |
Why?
|
Family Relations | 1 | 2015 | 318 | 0.110 |
Why?
|
Nevirapine | 2 | 2011 | 273 | 0.110 |
Why?
|
Culture | 2 | 2015 | 624 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1215 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1734 | 0.110 |
Why?
|
Electronic Prescribing | 1 | 2014 | 114 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 591 | 0.110 |
Why?
|
Africa | 2 | 2013 | 726 | 0.110 |
Why?
|
Drug Prescriptions | 3 | 2016 | 1677 | 0.110 |
Why?
|
Governing Board | 1 | 2013 | 50 | 0.110 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2016 | 352 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2131 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 621 | 0.100 |
Why?
|
HIV-1 | 1 | 2010 | 6909 | 0.100 |
Why?
|
Government Agencies | 1 | 2013 | 161 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2019 | 2362 | 0.100 |
Why?
|
Cultural Characteristics | 2 | 2012 | 250 | 0.100 |
Why?
|
London | 3 | 2017 | 233 | 0.100 |
Why?
|
Thinking | 2 | 2012 | 320 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 76 | 0.100 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2016 | 395 | 0.100 |
Why?
|
Risk-Taking | 2 | 2011 | 1041 | 0.100 |
Why?
|
Bacteremia | 1 | 2019 | 985 | 0.100 |
Why?
|
Observer Variation | 3 | 2019 | 2622 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2024 | 81835 | 0.100 |
Why?
|
Gastroenterology | 1 | 2019 | 588 | 0.100 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2930 | 0.100 |
Why?
|
Quality Improvement | 3 | 2017 | 3858 | 0.100 |
Why?
|
Aged, 80 and over | 9 | 2021 | 59679 | 0.100 |
Why?
|
Community Health Services | 1 | 2017 | 659 | 0.100 |
Why?
|
Drug Therapy, Combination | 3 | 2011 | 6320 | 0.100 |
Why?
|
Models, Biological | 2 | 2009 | 9505 | 0.100 |
Why?
|
Human Rights | 1 | 2014 | 312 | 0.100 |
Why?
|
Outpatients | 2 | 2016 | 1607 | 0.090 |
Why?
|
Diet | 2 | 2020 | 8098 | 0.090 |
Why?
|
Focus Groups | 3 | 2006 | 1448 | 0.090 |
Why?
|
Turkmenistan | 1 | 2010 | 3 | 0.090 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2012 | 239 | 0.090 |
Why?
|
Georgia | 2 | 2022 | 186 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5426 | 0.090 |
Why?
|
Organizational Policy | 1 | 2013 | 434 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2019 | 1389 | 0.090 |
Why?
|
Causality | 1 | 2017 | 1255 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2011 | 102 | 0.090 |
Why?
|
Choice Behavior | 1 | 2016 | 846 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 386 | 0.090 |
Why?
|
Social Environment | 1 | 2015 | 1026 | 0.090 |
Why?
|
HIV Seronegativity | 1 | 2011 | 211 | 0.090 |
Why?
|
Zambia | 1 | 2011 | 273 | 0.090 |
Why?
|
Home Care Services | 1 | 2017 | 655 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2014 | 365 | 0.090 |
Why?
|
Ukraine | 2 | 2008 | 151 | 0.090 |
Why?
|
Congresses as Topic | 2 | 2018 | 810 | 0.090 |
Why?
|
Technology | 1 | 2012 | 296 | 0.080 |
Why?
|
Communicable Diseases, Emerging | 1 | 2011 | 149 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 2 | 2012 | 792 | 0.080 |
Why?
|
Labor, Obstetric | 1 | 2013 | 323 | 0.080 |
Why?
|
Mass Media | 1 | 2012 | 304 | 0.080 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 849 | 0.080 |
Why?
|
Abortion, Induced | 1 | 2015 | 475 | 0.080 |
Why?
|
Drug Users | 1 | 2010 | 134 | 0.080 |
Why?
|
Blood Glucose | 2 | 2023 | 6429 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8559 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2179 | 0.080 |
Why?
|
Unsafe Sex | 1 | 2010 | 239 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 843 | 0.080 |
Why?
|
Confidentiality | 1 | 2013 | 606 | 0.080 |
Why?
|
Refugees | 1 | 2016 | 612 | 0.080 |
Why?
|
Autopsy | 1 | 2012 | 1013 | 0.080 |
Why?
|
Social Marketing | 1 | 2008 | 52 | 0.080 |
Why?
|
Vaccination | 4 | 2022 | 3433 | 0.080 |
Why?
|
Latent Tuberculosis | 1 | 2011 | 224 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2015 | 1487 | 0.070 |
Why?
|
Obesity | 4 | 2024 | 13065 | 0.070 |
Why?
|
Social Change | 2 | 2021 | 153 | 0.070 |
Why?
|
Immunization | 1 | 2012 | 1220 | 0.070 |
Why?
|
Esophagoscopy | 1 | 2009 | 398 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1637 | 0.070 |
Why?
|
Nutritional Status | 1 | 2015 | 1623 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 4861 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4877 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3253 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5994 | 0.070 |
Why?
|
Physicians | 3 | 2017 | 4615 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2021 | 65408 | 0.070 |
Why?
|
Drug Evaluation | 1 | 2008 | 642 | 0.070 |
Why?
|
Mammography | 1 | 2017 | 2436 | 0.070 |
Why?
|
Sexual Partners | 1 | 2011 | 806 | 0.070 |
Why?
|
Organizations | 2 | 2021 | 172 | 0.070 |
Why?
|
Political Systems | 1 | 2005 | 23 | 0.070 |
Why?
|
Pregnant Women | 1 | 2011 | 576 | 0.060 |
Why?
|
Self Report | 3 | 2023 | 3771 | 0.060 |
Why?
|
Malawi | 3 | 2011 | 308 | 0.060 |
Why?
|
Social Support | 1 | 2015 | 2195 | 0.060 |
Why?
|
Housing | 1 | 2010 | 679 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1947 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12096 | 0.060 |
Why?
|
Ethiopia | 2 | 2021 | 481 | 0.060 |
Why?
|
Hepatitis B Vaccines | 2 | 2020 | 177 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 794 | 0.060 |
Why?
|
Australia | 1 | 2009 | 1264 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2561 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13589 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2190 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2008 | 341 | 0.060 |
Why?
|
Medical Audit | 1 | 2006 | 454 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1599 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2013 | 1089 | 0.060 |
Why?
|
Hospitals, Private | 1 | 2024 | 67 | 0.060 |
Why?
|
Caregivers | 1 | 2017 | 2302 | 0.060 |
Why?
|
Sexually Transmitted Diseases | 1 | 2010 | 665 | 0.060 |
Why?
|
Isoniazid | 3 | 2012 | 288 | 0.060 |
Why?
|
Radiation Oncology | 2 | 2024 | 573 | 0.060 |
Why?
|
Saudi Arabia | 1 | 2024 | 212 | 0.060 |
Why?
|
Malnutrition | 1 | 2010 | 632 | 0.060 |
Why?
|
Benchmarking | 1 | 2010 | 1058 | 0.050 |
Why?
|
Epidemiology | 1 | 2006 | 280 | 0.050 |
Why?
|
Population Dynamics | 1 | 2005 | 314 | 0.050 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2005 | 361 | 0.050 |
Why?
|
Drugs, Essential | 1 | 2024 | 71 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 30031 | 0.050 |
Why?
|
Pulmonary Medicine | 1 | 2005 | 222 | 0.050 |
Why?
|
Demography | 2 | 2020 | 1643 | 0.050 |
Why?
|
Trust | 1 | 2008 | 532 | 0.050 |
Why?
|
Health Services Misuse | 1 | 2005 | 249 | 0.050 |
Why?
|
Length of Stay | 3 | 2024 | 6521 | 0.050 |
Why?
|
Risk | 2 | 2021 | 9642 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1339 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Counseling | 1 | 2010 | 1548 | 0.050 |
Why?
|
Prejudice | 1 | 2006 | 574 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 829 | 0.050 |
Why?
|
Decision Making | 2 | 2019 | 3961 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2724 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 2959 | 0.050 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2005 | 250 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4049 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2023 | 9177 | 0.050 |
Why?
|
Federal Government | 1 | 2003 | 266 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2011 | 1374 | 0.050 |
Why?
|
Cross-Cultural Comparison | 2 | 2015 | 639 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 191 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 406 | 0.050 |
Why?
|
Thailand | 1 | 2022 | 288 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7449 | 0.050 |
Why?
|
Public Health Administration | 1 | 2003 | 242 | 0.050 |
Why?
|
Ethics, Medical | 1 | 2006 | 785 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2012 | 1931 | 0.050 |
Why?
|
Injury Severity Score | 1 | 2024 | 1053 | 0.050 |
Why?
|
Bacteriological Techniques | 2 | 2012 | 277 | 0.050 |
Why?
|
Public Opinion | 2 | 2019 | 487 | 0.040 |
Why?
|
Saint Vincent and the Grenadines | 1 | 2020 | 2 | 0.040 |
Why?
|
Guyana | 1 | 2020 | 17 | 0.040 |
Why?
|
Bhutan | 1 | 2020 | 61 | 0.040 |
Why?
|
Social Security | 1 | 2020 | 101 | 0.040 |
Why?
|
Mass Screening | 3 | 2011 | 5455 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2011 | 5308 | 0.040 |
Why?
|
Women, Working | 1 | 2020 | 86 | 0.040 |
Why?
|
Decision Support Systems, Clinical | 1 | 2009 | 1176 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39429 | 0.040 |
Why?
|
Communication | 2 | 2016 | 3910 | 0.040 |
Why?
|
Kazakhstan | 1 | 2018 | 19 | 0.040 |
Why?
|
Papillomavirus Vaccines | 2 | 2019 | 497 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 301 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2019 | 148 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20232 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2005 | 1320 | 0.040 |
Why?
|
Holistic Health | 1 | 2018 | 48 | 0.040 |
Why?
|
Nigeria | 1 | 2021 | 777 | 0.040 |
Why?
|
Foodborne Diseases | 1 | 2018 | 41 | 0.040 |
Why?
|
Teaching | 1 | 2006 | 1174 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1382 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 758 | 0.040 |
Why?
|
Logistic Models | 2 | 2024 | 13323 | 0.040 |
Why?
|
Population Density | 1 | 2018 | 193 | 0.040 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 450 | 0.040 |
Why?
|
Social Responsibility | 1 | 2020 | 385 | 0.040 |
Why?
|
Dyslipidemias | 1 | 2024 | 874 | 0.030 |
Why?
|
Kenya | 1 | 2020 | 757 | 0.030 |
Why?
|
Tanzania | 1 | 2021 | 1405 | 0.030 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2008 | 1472 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2006 | 1081 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 823 | 0.030 |
Why?
|
Depression | 1 | 2016 | 8235 | 0.030 |
Why?
|
Climate Change | 1 | 2023 | 508 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2012 | 22286 | 0.030 |
Why?
|
Tsunamis | 1 | 2017 | 61 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20763 | 0.030 |
Why?
|
Syria | 1 | 2016 | 86 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2339 | 0.030 |
Why?
|
Nurses | 1 | 2006 | 2494 | 0.030 |
Why?
|
Lebanon | 1 | 2016 | 244 | 0.030 |
Why?
|
Smoking | 2 | 2024 | 9099 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2019 | 949 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1587 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 717 | 0.030 |
Why?
|
Disaster Planning | 1 | 2021 | 560 | 0.030 |
Why?
|
Risk Assessment | 4 | 2021 | 24310 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 785 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13709 | 0.030 |
Why?
|
Earthquakes | 1 | 2017 | 192 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1395 | 0.030 |
Why?
|
Public Health Practice | 1 | 2016 | 221 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2286 | 0.030 |
Why?
|
Polypharmacy | 1 | 2016 | 307 | 0.030 |
Why?
|
Problem Solving | 1 | 2016 | 443 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2008 | 2969 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1608 | 0.030 |
Why?
|
Communication Barriers | 1 | 2016 | 419 | 0.030 |
Why?
|
Incubators, Infant | 1 | 2012 | 6 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1418 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36840 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 627 | 0.030 |
Why?
|
Sanitation | 1 | 2012 | 83 | 0.020 |
Why?
|
Tropical Medicine | 1 | 2012 | 52 | 0.020 |
Why?
|
History, 19th Century | 1 | 2014 | 716 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2768 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2910 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2012 | 70 | 0.020 |
Why?
|
Ambulances | 1 | 2012 | 93 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2710 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3637 | 0.020 |
Why?
|
Hepacivirus | 1 | 2019 | 1342 | 0.020 |
Why?
|
Patient Transfer | 1 | 2019 | 796 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2048 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3207 | 0.020 |
Why?
|
Animals | 3 | 2016 | 169424 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6856 | 0.020 |
Why?
|
Water Supply | 1 | 2012 | 204 | 0.020 |
Why?
|
Education, Medical | 1 | 2003 | 1742 | 0.020 |
Why?
|
Disasters | 1 | 2017 | 522 | 0.020 |
Why?
|
Mass Vaccination | 1 | 2012 | 110 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2006 | 4538 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1337 | 0.020 |
Why?
|
Rural Health | 1 | 2012 | 300 | 0.020 |
Why?
|
Hunger | 1 | 2012 | 207 | 0.020 |
Why?
|
Jordan | 1 | 2010 | 73 | 0.020 |
Why?
|
Pakistan | 1 | 2011 | 298 | 0.020 |
Why?
|
Workplace | 1 | 2016 | 872 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1227 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2015 | 539 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1965 | 0.020 |
Why?
|
Esophagoscopes | 1 | 2009 | 16 | 0.020 |
Why?
|
Lamivudine | 1 | 2011 | 368 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6995 | 0.020 |
Why?
|
Smoking Cessation | 2 | 2012 | 2078 | 0.020 |
Why?
|
Colombia | 1 | 2010 | 285 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4841 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4052 | 0.020 |
Why?
|
Inservice Training | 1 | 2012 | 377 | 0.020 |
Why?
|
Zidovudine | 1 | 2011 | 625 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4355 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5880 | 0.020 |
Why?
|
Malaria, Vivax | 1 | 2010 | 166 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 553 | 0.020 |
Why?
|
Foot | 1 | 2012 | 577 | 0.020 |
Why?
|
Advisory Committees | 1 | 2012 | 797 | 0.020 |
Why?
|
Rwanda | 1 | 2010 | 669 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2008 | 121 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5912 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2018 | 1468 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2012 | 595 | 0.020 |
Why?
|
Lung Diseases | 1 | 2017 | 1926 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2012 | 821 | 0.020 |
Why?
|
Equipment and Supplies | 1 | 2009 | 273 | 0.020 |
Why?
|
Cohort Studies | 2 | 2006 | 41782 | 0.020 |
Why?
|
Bed Occupancy | 1 | 2006 | 38 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5940 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8372 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2012 | 1279 | 0.020 |
Why?
|
Informed Consent | 1 | 2012 | 1012 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14725 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15459 | 0.010 |
Why?
|
Republic of Belarus | 1 | 2004 | 38 | 0.010 |
Why?
|
Disease Notification | 1 | 2005 | 95 | 0.010 |
Why?
|
Rifampin | 1 | 2006 | 345 | 0.010 |
Why?
|
Anemia, Sickle Cell | 1 | 2012 | 1065 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8762 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6657 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2011 | 1539 | 0.010 |
Why?
|
Prospective Studies | 2 | 2024 | 54913 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3267 | 0.010 |
Why?
|
Milk | 1 | 2005 | 445 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2011 | 1462 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4630 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8051 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2119 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2655 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2861 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7955 | 0.010 |
Why?
|
Drug Utilization | 1 | 2004 | 1192 | 0.010 |
Why?
|
Patient Care Team | 1 | 2009 | 2526 | 0.010 |
Why?
|
ROC Curve | 1 | 2005 | 3623 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11515 | 0.010 |
Why?
|
Stroke | 1 | 2017 | 9790 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8510 | 0.010 |
Why?
|
Odds Ratio | 1 | 2005 | 9687 | 0.010 |
Why?
|
Curriculum | 1 | 2006 | 3778 | 0.010 |
Why?
|